Susceptibility to respiratory infections associated with CD8alpha chain mutation

Susceptibility to respiratory infections associated with CD8 alpha chain mutation (also known as CD8 deficiency or CD8alpha chain deficiency) is an extremely rare primary immunodeficiency disorder caused by mutations in the CD8A gene, which encodes the alpha chain of the CD8 glycoprotein. CD8 is a cell surface molecule expressed on a subset of T lymphocytes (CD8+ T cells) that plays a critical role in immune defense, particularly against viral infections and intracellular pathogens. Mutations in the CD8A gene lead to a selective deficiency of CD8+ T cells, impairing the body's ability to mount effective cytotoxic T-cell responses. Affected individuals primarily experience increased susceptibility to recurrent respiratory tract infections, including sinusitis, bronchitis, and pneumonia. Despite the absence or marked reduction of CD8+ T cells, the clinical phenotype can be relatively mild in some patients, suggesting that other components of the immune system may partially compensate for the deficiency. The condition primarily affects the immune system and, consequently, the respiratory system due to recurrent infections. There is currently no specific curative treatment for CD8 alpha chain deficiency. Management is primarily supportive and focuses on the prompt treatment of infections with appropriate antimicrobial agents and, in some cases, prophylactic antibiotics to reduce the frequency of respiratory infections. Immunoglobulin replacement therapy may be considered if concurrent humoral immune defects are identified. Hematopoietic stem cell transplantation could theoretically be curative but has not been widely reported for this specific condition given its relative clinical mildness in described cases. Genetic counseling is recommended for affected families.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Susceptibility to respiratory infections associated with CD8alpha chain mutation